Navigation Links
The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR


Introduction
CypHer5TM is a red-excited, pH-sensitive cyanine dye that is non-fluorescent at pH 7.4 and maximally fluorescent at pH 5.5. It is therefore ideally suited for monitoring internalization of cell surface receptors via acidic endosomal vesicles upon agonist stimulation (1, 2).

In the assay, the receptor can be epitope-tagged and an antibody recognizing the tag is then labelled with CypHer5. Alternatively, an endogenous antibody that recognizes an exofacial epitope can be labelled directly with CypHer5. Agonist-induced internalization of the receptor is then measured as an increase in fluorescence in the cell. This offers an advantage over other techniques that rely solely on measuring a translocation in fluorescent signal. Many other commonly used techniques such as b-arrestin recruitment, Ca2+ flux, and cAMP measurement are only suitable for use with G-protein coupled receptors (GPCRs). In contrast, CypHer5 is functional with both GPCRs and non-GPCRs that internalize in response to external stimuli.

GPCRs represent an important area for target validation. To demonstrate the generic applicability of CypHer5 pH-sensitive dye, examples of the GPCR subfamilies Gi (δ -opioid receptor), Gq (TRHR-1, angiotensin II) and Gs (β -2 adrenergic receptor) (3) were studied. These assays involve the use of CypHer5 labelled anti-VSV-G antibody to detect the VSV-G tagged receptors.

Epidermal growth factor receptor (EGFR) plays a central role in the complex signaling pathways involved in cell growth and differentiation (4) and is an example of a non-GPCR that is widely studied. The assay described here uses an exofacial antibody for EGFR that is directly labelled with CypHer5 Mono NHS Ester.


Products used
CypHer5 labelled anti-VSV-G antibody, 250 mg PA45407

'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000
2. The use of CypHer5E and the IN Cell Analyzer 1000 for live-cell receptor internalization studies
3. Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000
4. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
5. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
6. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
7. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System
8. Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System
9. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
10. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
11. The development of a somatostatin sst4 receptor-binding assay using the LEADseeker Multimodality Imaging System
Post Your Comments:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... ... to market the TriPollar Technology- the most advanced 3rd generation Radio Frequency ... been clinically proven the world over to be safe and effective on ... enjoy visible results from the very 1st treatment. Long term results ...
... ... Ingelheim today announced results from the RE-COVER(TM) study investigating dabigatran etexilate ... warfarin in patients with acute VTE. Results of the trial ... and simultaneously published online in the New England Journal of ...
... , , Alberta Centre for Advanced ... & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ... like nanotechnology, biomaterials and microfluidics can play a powerful role ... health and improve the quality, cost and outcomes of patient ...
Cached Biology Technology:Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Alberta companies delivering new products to the health & medical marketplace 2
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ... 2015-2019"  report to their offering. ... advances in technology. With continuous advances in technology, ... the latest standard that meets the needs and ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical ... building for its School of Medicine. Funding for this ... capital campaign that will be publicly launched next summer. ... located in the former 60 series R.J. Reynolds Tobacco ... Quarter. Construction will begin immediately with plans to be ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... or persistent seizures into a medically induced coma currently ... monitor the patient,s brain activity and manually adjust drug ... Now a computer-controlled system developed by Massachusetts General Hospital ... more precise and efficient and opening the door to ...
... bad thing, but experiments by researcher Peter Chien and ... Amherst recently showed that for the bacteria Caulobacter ... is required to keep it alive. DNA ... processes in all organisms, says Chien, an assistant professor ...
... Mich. Researchers from the University of Michigan Comprehensive ... function of critical immune cell subsets called T-cells, which ... effect of lifesaving bone marrow transplants. These new ... T-cells help fight infections but also can trigger autoimmune ...
Cached Biology News:Automated system promises precise control of medically induced coma 2Automated system promises precise control of medically induced coma 3Biochemists find incomplete protein digestion is a useful thing for some bacteria 2Newly identified proteins make promising targets for blocking graft-vs.-host disease 2
... deparaffinize and perform Heat Induced Antigen Retrieval ... mounted on glass microscope slides. Deparffinization is ... high temperature used in HIER (over 90degrees ... by detergent. Formaldehyde fixation impairs or totally ...
... Bovine Calf Serum; U.S. ... seek an uncompromising quality; Low ... Collected from animals of US ... those who seek an uncompromising ...
Collected from animals of U.S. origin.Collected from animals of U.S. origin. *Can be used in cell growth studies and immunoassays. *Sterility tested, * Mycoplasma tested upon request, *Endoto...
...
Biology Products: